Medical Properties Trust, Inc. (MPT) Stock Analysis

A high-leverage hospital REIT in mid-turnaround: MPT’s re-tenanting execution and 2026–2027 refinancing will decide whether today’s deep discount becomes a recovery rerate or a value trap.

Overview

Medical Properties Trust (MPT) is a self-advised hospital-focused REIT founded in 2003 that built a global portfolio by acquiring hospital real estate and leasing it back to operators under long-term, triple-net leases designed to produce predictable, inflation-protected cash flows. As of FY2025, it owned **384 properties (~39,000 licensed beds) across nine countries**, with assets concentrated in general acute care hospitals ($8.9B of $15.0B assets), plus behavioral health and post-acute/rehab. FY2025 was defined by restructuring after Steward’s bankruptcy and Prospect’s reorganization: by early 2026, MPT had re-tenanted **17 former Steward hospitals** to five new operators and regained control of key real estate through a global settlement. Financial results improved sharply from 2024’s impairment-driven collapse (net loss $2.4B) to a smaller FY2025 net loss ($277M), with **Q4 2025 returning to GAAP profit** ($17M). However, cash-flow metrics remain pressured: **NFFO fell to $0.58/share** from $0.80 due to rent ramps/deferrals and higher interest expense after refinancing. Management’s near-term agenda is balance-sheet fortification and restoring cash rent, targeting **≥$1B pro forma annualized cash rent by end-2026**, supported by selective asset sales, a reinstated but reduced dividend, and a $150M buyback authorization. The core question for investors is whether execution through 2026–2027 (tenant stabilization plus refinancing) converts the stock’s depressed valuation into a sustained recovery.

Read the full Medical Properties Trust, Inc. research report

Loading the interactive MPT dashboard…